Page 12«..11121314..2030..»

Category Archives: MS Treatment

Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021 – Business Wire

Posted: Published on October 5th, 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), today announced the upcoming full release of new translational data and two-year open-label extension (OLE) clinical data from the study of ATA188 in progressive multiple sclerosis (MS). Continue reading

Posted in MS Treatment | Comments Off on Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021 – Business Wire

TG Therapeutics Submits Biologics License Application to the US Food and Drug Administration for Ublituximab as a Treatment for Patients with…

Posted: Published on October 5th, 2021

NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc., (NASDAQ: TGTX), today announced the submission of a Biologics License Application (BLA) to theU.S Continue reading

Posted in MS Treatment | Comments Off on TG Therapeutics Submits Biologics License Application to the US Food and Drug Administration for Ublituximab as a Treatment for Patients with…

Oxford, MS – Jackson Ave W Scene of Car Crash with Injuries – Germany Law Firm PLLC – Bob Germany Law

Posted: Published on October 5th, 2021

Oxford, MS (October 4, 2021) According to local officials, at least one person was hurt in a vehicle crash in Oxford on Monday, October 4. According to early reports, the incident occurred around 3:05 p.m. Continue reading

Posted in MS Treatment | Comments Off on Oxford, MS – Jackson Ave W Scene of Car Crash with Injuries – Germany Law Firm PLLC – Bob Germany Law

BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa – WWNY

Posted: Published on October 5th, 2021

Published: Oct. 4, 2021 at 6:00 AM EDT NEW YORK, Oct. 4, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc Continue reading

Posted in MS Treatment | Comments Off on BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa – WWNY

Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics – Yahoo Finance

Posted: Published on October 5th, 2021

Agreement Marks the Official Launch of Lanier, a Georgia-Based Biopharmaceutical Company Developing a Robust Portfolio of First-in-Class Antibody Candidates BOGART, Ga., Oct. Continue reading

Posted in MS Treatment | Comments Off on Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics – Yahoo Finance

International Brain Tumor Patient Headed Home After Treatment at Miami Cancer Institute – Baptist Health South Florida

Posted: Published on May 12th, 2021

When Paula Vargas started complaining about random headaches and problems seeing out of her right eye, the thriving, 27-year-old lawyer thought that stress from work might be causing the issues. After seeing her doctor in her native city of Bogota, Colombia, scans and tests revealed something much more serious. Ms. Continue reading

Posted in MS Treatment | Comments Off on International Brain Tumor Patient Headed Home After Treatment at Miami Cancer Institute – Baptist Health South Florida

Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects – DocWire…

Posted: Published on May 12th, 2021

This article was originally published here Neurol Res Pract. Continue reading

Posted in MS Treatment | Comments Off on Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects – DocWire…

South Jersey MS Center Now Offering TMS Therapy For Those With Chronic Treatment-Resistant Illnesses – WFMZ Allentown

Posted: Published on May 12th, 2021

SCOTCH PLAINS, N.J., May 11, 2021 /PRNewswire-PRWeb/ -- Dr. Steven M. Bromley, Dr Continue reading

Posted in MS Treatment | Comments Off on South Jersey MS Center Now Offering TMS Therapy For Those With Chronic Treatment-Resistant Illnesses – WFMZ Allentown

Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden…

Posted: Published on May 12th, 2021

This article was originally published here J Med Econ. 2021 May 8:1 Continue reading

Posted in MS Treatment | Comments Off on Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden…

Treatment and decision-making process in multiple sclerosis | PPA – Dove Medical Press

Posted: Published on May 12th, 2021

Introduction Multiple sclerosis (MS) is a chronic degenerative disease of the central nervous system affecting 700,000 persons in Europe. Continue reading

Posted in MS Treatment | Comments Off on Treatment and decision-making process in multiple sclerosis | PPA – Dove Medical Press

Page 12«..11121314..2030..»